Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Enovis Corporation

Market Cap 1.26B 1.1B 1.02B 956M 1.79B 119B 1.8B 12.12B 4.7B 58.74B 4.75B 4.65B 204B P/E 2026 *
181x
P/E 2027 * 22.8x
Enterprise Value 2.46B 2.15B 1.99B 1.86B 3.49B 232B 3.51B 23.59B 9.14B 114B 9.24B 9.04B 397B EV / Sales 2026 *
1.05x
EV / Sales 2027 * 0.94x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+5.37%
1 week+0.78%
Current month-3.13%
1 month-16.97%
3 months+0.55%
6 months-17.90%
Current year-17.53%
1 week 20.61
Extreme 20.61
22.71
1 month 20.55
Extreme 20.55
25.29
Current year 20.55
Extreme 20.55
29.89
1 year 20.55
Extreme 20.55
36.82
3 years 20.55
Extreme 20.55
66.14
5 years 20.55
Extreme 20.55
164.01
10 years 20.55
Extreme 20.55
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Chief Administrative Officer

1,000 0.0017%
06-10Buy

Chief Administrative Officer

1,200 0.0021%
06-10Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+5.37%+0.78%-27.03%-63.37% 1.26B
+2.21%-1.41%-18.04%+3.36% 118B
-0.66%-0.71%+4.21%-9.57% 12.63B
+2.57%+3.05%+30.48%+96.25% 7.67B
+0.48%-3.09%-46.72%-71.26% 4.07B
+1.51%+0.28%+19.47%+34.70% 2.55B
+0.94%-1.24%-14.22%-14.09% 1.77B
-0.21%-4.06%+4.27%-21.68% 1.59B
+5.36%+9.88%+189.38%+141.43% 1.49B
Average +1.95%+1.33%+15.76%+10.64% 16.78B
Weighted average by Cap. +1.95%+0.76%-11.61%+5.85%

Financials

2026 *2027 *
Net sales 2.34B 2.04B 1.89B 1.77B 3.32B 221B 3.34B 22.46B 8.71B 109B 8.8B 8.61B 378B 2.47B 2.15B 1.99B 1.86B 3.5B 233B 3.52B 23.63B 9.16B 115B 9.26B 9.06B 398B
Net income 2.96M 2.58M 2.39M 2.24M 4.2M 279M 4.22M 28.36M 10.99M 137M 11.11M 10.87M 477M 54.22M 47.27M 43.78M 40.99M 76.87M 5.12B 77.33M 519M 201M 2.52B 204M 199M 8.74B
Net Debt 1.2B 1.04B 967M 905M 1.7B 113B 1.71B 11.47B 4.45B 55.61B 4.49B 4.4B 193B 1.07B 929M 861M 806M 1.51B 101B 1.52B 10.21B 3.96B 49.51B 4B 3.92B 172B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
18/06/26 21.97 $ +5.37% 1,799,377
17/06/26 20.85 $ -3.38% 1,101,769
16/06/26 21.58 $ +2.86% 1,076,261
15/06/26 20.98 $ -3.76% 845,447
12/06/26 21.80 $ +3.22% 907,673
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
21.97USD
Average target price
42.30USD
Spread / Average Target
+92.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!